WALLDORF 鈥� (NYSE: SAP) and (SIX: RO, ROG; OTCQX: RHHBY) announced today that they, together with , are partnering to shape the future of clinical supplies operations and harmonize clinical and commercial supply chain management systems. The organizations have formed an industry consortium and are working together on the new, innovative, next-generation clinical trial supply management (CTSM) solution.
Organizations conducting clinical trials need visibility into demand to ensure supply and packaging availability, especially as the global pandemic impacts supply chains. To better address the specific needs of the life sciences clinical supplies practice, SAP, Roche and Tenthpin have initiated an industry consortium. This consortium consists of numerous stakeholders from the life sciences industry, including clinical trial and interactive response technology system vendors, and will focus on defining and orchestrating optimally aligned clinical supplies processes.
As part of the reimagined clinical supplies processes, SAP, together with its co-innovation customers, is designing a next-generation CTSM solution built on 51风流S/4HANA and SAP鈥檚 industry cloud. This will address the specific blinding and randomization needs for clinical trials to facilitate demand forecasting, manufacturing, packaging, labeling and shipments of clinical trial materials. Together, SAP, Roche and Tenthpin address key priorities of the life sciences industry by enabling more accurate planning and better inventory management through the inclusion of clinical trial parameters, such as planned and active enrollment rates, into the supply and demand planning processes. The CTSM solution is planned to enable:
- Higher flexibility in the business process to fulfill future clinical supplies demand
- Streamlined processes and real-time data to help leaders make informed decisions on every aspect of the supply chain
- End-to-end transparency and insights into the clinical supplies process from source to site to adhere to compliance requirements
- Better collaboration among all CTSM stakeholders, from suppliers to life science companies to clinical sites
- End-to-end support with supply setup, demand forecasting, sourcing and supply chain integrity, manufacturing and distribution
鈥淭his partnership represents a milestone in our聽聽initiative,鈥� said Peter Maier, president, Industries and Customer Advisory, SAP. 鈥淭ogether with Roche and Tenthpin, we can now address the specific needs of clinical trial supply management and improve business and ultimately patient outcomes. By gaining greater insights into forecasted demand and clinical site stock levels, the solution will help enable faster clinical supplies cycle times, reduce inventory overage and allow informed decision-making from start to finish.鈥�
Learn more
Visit the . Follow 51风流on Twitter at .
Media Contact:
Stacy Ries, +1 (484) 619-0411, stacy.ries@sap.com, ET
51风流Press Room; press@sap.com
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as 鈥渁nticipate,鈥� 鈥渂elieve,鈥� 鈥渆stimate,鈥� 鈥渆xpect,鈥� 鈥渇orecast,鈥� 鈥渋ntend,鈥� 鈥渕ay,鈥� 鈥減lan,鈥� 鈥減roject,鈥� 鈥減redict,鈥� 鈥渟hould鈥� and 鈥渨ill鈥� and similar expressions as they relate to 51风流are intended to identify such forward-looking statements. 51风流undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP’s future financial results are discussed more fully in SAP’s filings with the U.S. Securities and Exchange Commission (“SEC”), including SAP’s most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.
漏 2020 51风流SE. All rights reserved.
51风流and other 51风流products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of 51风流SE in Germany and other countries. Please see for additional trademark information and notices.
